SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Generate Capital ("Generate"), a leading investor, owner and operator of critical infrastructure, today announced the closing of a $117 million term debt ...

A clever technique used to hide malicious prompts in attacks on AI agents has been adopted by spammers to evade filters on email platforms that are designed to flag unwanted messages used in mass ...

To be clear: There are no official, task-specific “RV generators,” but some portable generators are better-suited to the task than others. For starters, most RVs have a 30-amp (A) outlet that lets you ...

本ブログは 2024 年 2 月 12 日に公開された AWS Blog “Identify Java nested dependencies with Amazon Inspector SBOM Generator” を翻訳したものです。公開後のサービスアップデートを訳注として補足しています。

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...